(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Entrusted Wealth Management with Temporarily Idle Funds for Q3 2026
Filed with SSE · Stock code 600998 · · 7 pages · Chinese
Summary by 6ix AI
It emphasizes that the investments will not affect the company's normal operations and aims to enhance the efficiency of fund usage. The company has established risk management measures to mitigate potential financial risks involved in these investments.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Story so far
Earlier from Jointown Pharmaceutical
- Announcement on Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Person Acting in Concert
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- Announcement on Progress in Providing Guarantees for Subsidiaries
- Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026
- Announcement on Outline of the 2026 Semi-annual Performance Briefing
Later from Jointown Pharmaceutical
- (600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance Results of the 3rd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)
- (600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Acquisition of Patents in Q3 2026
- (600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Industrial and Commercial Registration Changes and Filing of the Articles of Association
- (600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for Subsidiaries
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical